The project is expected to get underway in March 2025. Zydus Lifesciences on Tuesday said it will undertake development of a combination vaccine against shigellosis and typhoid. The company, with ...

The Trust has purchased the apartment on the 61st floor of Tower A, which is 17,384 sq ft big, according to documents accessed through portal IndexTap, a data-driven home buying platform.

Zydus Family Trust has bought an apartment in Oberoi Realty’s luxury housing project in Worli, Mumbai, for Rs 200 crore, according to IndexTap.com. The size of the flat is 17,384 sq ft and the ...

The recent approval enables Zydus Lifesciences to produce and sell Apalutamide Tablets, 60 mg (a generic equivalent of Erleada) in the United States. Apalutamide is an androgen receptor inhibitor ...

Zydus Lifesciences announced today it will develop the world’s first combination vaccine targeting both typhoid fever and shigellosis, with financial backing from the Bill & Melinda Gates ...

Zydus Lifesciences Limited on Tuesday announced that the company has entered into exclusive negotiations to acquire majority Amplitude Surgical. Purchase consideration amounts to €256.8mn for 85 ...

“In Amplitude Surgical, we see several medium-term and long-term growth opportunities with respect to portfolio, capabilities, manufacturing and geographies,” says Dr Sharvil Patel, Managing ...

CMV infection remains one of the most serious complications in transplant patients. (Image Credits: Pixabay) Zydus on Wednesday said that a breakthrough in the prevention of Cytomegalovirus (CMV ...

Zydus Lifesciences has entered exclusive negotiations to acquire a controlling stake in France-based medtech firm Amplitude Surgical SA for €256.8 million, the drugmaker said on Tuesday, as it ...

Zydus Lifesciences has entered into exclusive negotiations to acquire a controlling 85.6 percent stake in France-based Amplitude Surgical SA, a leading medical technology company specialising in ...

New Delhi: Indian pharma major Zydus Lifesciences has entered into exclusive negotiations to acquire a majority stake in France-based orthopedic device maker Amplitude Surgical for up to €300 ...

Zydus, a leading, discovery-based, global lifesciences company, announces the launch of ANVIMO (Letermovir), a breakthrough in the prevention of Cytomegalovirus (CMV) infection for haematopoietic ...